FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386811441> ?p ?o ?g. }

• W4386811441 endingPage "601" @default.
• W4386811441 startingPage "587" @default.
• W4386811441 abstract "Systemic therapy for muscle-invasive bladder cancer (BC) remains dominated by cisplatin-based chemotherapy. However, resistance to cisplatin therapy greatly limits long-term survival. Resistance to cisplatin-based chemotherapy still needs to be addressed. In this study, we established three cisplatin-resistant BC cell lines by multiple cisplatin pulse treatments. Interestingly, after exposure to cisplatin, all cisplatin-resistant cell lines showed lower reactive oxygen species (ROS) levels than the corresponding parental cell lines. Using proteomic analysis, we identified 35 proteins that were upregulated in cisplatin-resistant BC cells. By knocking down eleven of these genes, we found that after CAB39 knockdown, BC cisplatin-resistant cells were more sensitive to cisplatin. Overexpression of CAB39 had the opposite effect. Then, the knockdown of six genes downstream of CAB39 revealed that CAB39 promoted cisplatin resistance in BC through LKB1. Moreover, a key cause of cisplatin-induced cell death is damage to mitochondria and increased ROS levels. In our study, cisplatin-resistant cells exhibited higher autophagic flux and healthier mitochondrial status after cisplatin exposure. We demonstrated that the CAB39-LKB1-AMPK-LC3 pathway plays a critical role in enhancing autophagy to maintain the health of mitochondria and reduce ROS levels. In addition, the autophagy inhibitor chloroquine (CQ) can significantly enhance the killing effect of cisplatin on BC cells. Compared with gemcitabine plus cisplatin (GC), GC plus CQ significantly reduced tumor burden in vivo. In conclusion, our study shows that CAB39 counteracts the killing of cisplatin by enhancing the autophagy of BC cells to damaged mitochondria and other organelles to alleviate the damage of cells caused by harmful substances such as ROS." @default.
• W4386811441 created "2023-09-18" @default.
• W4386811441 creator A5005181505 @default.
• W4386811441 creator A5007606629 @default.
• W4386811441 creator A5016765792 @default.
• W4386811441 creator A5028680526 @default.
• W4386811441 creator A5057866000 @default.
• W4386811441 creator A5063083500 @default.
• W4386811441 creator A5064580441 @default.
• W4386811441 creator A5070287856 @default.
• W4386811441 creator A5071052610 @default.
• W4386811441 creator A5077166272 @default.
• W4386811441 creator A5080783221 @default.
• W4386811441 creator A5089744573 @default.
• W4386811441 date "2023-11-01" @default.
• W4386811441 modified "2023-10-18" @default.
• W4386811441 title "CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway" @default.
• W4386811441 cites W1508781039 @default.
• W4386811441 cites W1544790145 @default.
• W4386811441 cites W1706227909 @default.
• W4386811441 cites W1966978656 @default.
• W4386811441 cites W1970637701 @default.
• W4386811441 cites W2019156893 @default.
• W4386811441 cites W2019683289 @default.
• W4386811441 cites W2073304532 @default.
• W4386811441 cites W2127192155 @default.
• W4386811441 cites W2146497623 @default.
• W4386811441 cites W2154756022 @default.
• W4386811441 cites W2158535250 @default.
• W4386811441 cites W2360057999 @default.
• W4386811441 cites W2581547394 @default.
• W4386811441 cites W2607129810 @default.
• W4386811441 cites W2736312781 @default.
• W4386811441 cites W2761245997 @default.
• W4386811441 cites W2781220711 @default.
• W4386811441 cites W2797956345 @default.
• W4386811441 cites W2892977673 @default.
• W4386811441 cites W2900160284 @default.
• W4386811441 cites W2918030842 @default.
• W4386811441 cites W2969669884 @default.
• W4386811441 cites W2975791438 @default.
• W4386811441 cites W2985611265 @default.
• W4386811441 cites W2991106430 @default.
• W4386811441 cites W2994352857 @default.
• W4386811441 cites W3005700710 @default.
• W4386811441 cites W3013397521 @default.
• W4386811441 cites W3023288864 @default.
• W4386811441 cites W3025549503 @default.
• W4386811441 cites W3033738814 @default.
• W4386811441 cites W3048201207 @default.
• W4386811441 cites W3086670596 @default.
• W4386811441 cites W3088227706 @default.
• W4386811441 cites W3093217304 @default.
• W4386811441 cites W3108936441 @default.
• W4386811441 cites W3113984524 @default.
• W4386811441 cites W3118761073 @default.
• W4386811441 cites W3127113383 @default.
• W4386811441 cites W3128646645 @default.
• W4386811441 cites W3139048697 @default.
• W4386811441 cites W3153388321 @default.
• W4386811441 cites W3161047142 @default.
• W4386811441 cites W3186305749 @default.
• W4386811441 cites W3206000803 @default.
• W4386811441 cites W3210209288 @default.
• W4386811441 cites W4200569725 @default.
• W4386811441 cites W4206781509 @default.
• W4386811441 cites W4213127832 @default.
• W4386811441 cites W4224239873 @default.
• W4386811441 cites W4224298467 @default.
• W4386811441 cites W4225255832 @default.
• W4386811441 cites W4283701282 @default.
• W4386811441 cites W4291782798 @default.
• W4386811441 cites W4320486234 @default.
• W4386811441 doi "https://doi.org/10.1016/j.freeradbiomed.2023.09.017" @default.
• W4386811441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37726090" @default.
• W4386811441 hasPublicationYear "2023" @default.
• W4386811441 type Work @default.
• W4386811441 citedByCount "0" @default.
• W4386811441 crossrefType "journal-article" @default.
• W4386811441 hasAuthorship W4386811441A5005181505 @default.
• W4386811441 hasAuthorship W4386811441A5007606629 @default.
• W4386811441 hasAuthorship W4386811441A5016765792 @default.
• W4386811441 hasAuthorship W4386811441A5028680526 @default.
• W4386811441 hasAuthorship W4386811441A5057866000 @default.
• W4386811441 hasAuthorship W4386811441A5063083500 @default.
• W4386811441 hasAuthorship W4386811441A5064580441 @default.
• W4386811441 hasAuthorship W4386811441A5070287856 @default.
• W4386811441 hasAuthorship W4386811441A5071052610 @default.
• W4386811441 hasAuthorship W4386811441A5077166272 @default.
• W4386811441 hasAuthorship W4386811441A5080783221 @default.
• W4386811441 hasAuthorship W4386811441A5089744573 @default.
• W4386811441 hasConcept C121608353 @default.
• W4386811441 hasConcept C126322002 @default.
• W4386811441 hasConcept C173396325 @default.
• W4386811441 hasConcept C185592680 @default.
• W4386811441 hasConcept C190283241 @default.
• W4386811441 hasConcept C203522944 @default.
• W4386811441 hasConcept C2776694085 @default.

• next